IDBAY — Idex Biometrics ASA Income Statement
0.000.00%
- $52.43m
- $43.61m
- $4.09m
Annual income statement for Idex Biometrics ASA, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | Interim Report | ARS | ARS | ARS |
Standards: | IFRS | — | IFRS | IFRS | IFRS |
Status: | fx Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.44 | 0.423 | 1.09 | 2.84 | 4.09 |
Cost of Revenue | |||||
Gross Profit | 0.256 | 0.361 | 0.82 | 1.59 | 0.847 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 30.4 | 32.5 | 27.5 | 34.2 | 35.5 |
Operating Profit | -29.9 | -32 | -26.4 | -31.4 | -31.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -30.2 | -32.3 | -26.9 | -32.5 | -32.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | -30.2 | -32.4 | -26.8 | -32.6 | -32.7 |
Net Income Before Extraordinary Items | |||||
Net Income | -30.2 | -32.4 | -26.8 | -32.6 | -32.7 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -30.2 | -32.4 | -26.8 | -32.6 | -32.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.056 | -0.054 | -0.034 | -0.035 | -0.032 |
Dividends per Share |